Under construction – not a live service
Sign in
Taking peopleNo phase

Platelet-rich fibrin placed in the inner ear during cochlear implant surgery

Tests platelet-rich fibrin in cochlear implant surgery for hearing loss.

Key facts

Who runs it
Pamukkale University
Where
Türkiye1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Intracochlear Platelet-rich Fibrin Application in Cochlear Implantation
Status
Recruiting
People taking part
10 people, planned
Started
31 Jan 2022
Expected to end
20 Dec 2028
Type of study
Interventional
Treatments tested
  • intracochlear platelet rich fibrin administration
Record updated
14 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people with sensorineural hearing loss (inner ear or nerve hearing loss) who will have cochlear implant surgery with the CI422 electrode.

Sex
All sexes can join.
Disease stage
Sensorineural hearing loss, with cochlear implant surgery planned.

Main reasons for not taking part

  • An abnormally formed cochlea (the snail-shaped part of the inner ear)
  • Auditory neuropathy (a problem with the hearing nerve passing sound signals)

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Patients with sensorineural hearing loss
  • Patients who will have cochlear implant surgery with CI422 electrode

Who cannot take part

  • Patients with cochlear abnormality
  • Patients with auditory neuropathy

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Fibrosis due to surgical trauma is a common problem with cochlear implants. Fibrosis limits the effectiveness of implant and increases the power consumption. Our aim in this study is to benefit from the anti-inflammatory effects of autologous platelet-rich fibrin to reducing the fibrotic cascade.

The group in the trial

  • intracochlear prf administration groupTreatment being tested

    Treatment: intracochlear platelet rich fibrin administration

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Intracochlear Platelet-rich Fibrin Application in Cochlear Implantation
Plain-language title
Platelet-rich fibrin placed in the inner ear during cochlear implant surgeryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
14 July 2026